{"id":68176,"date":"2026-06-15T20:25:05","date_gmt":"2026-06-15T12:25:05","guid":{"rendered":"https:\/\/flcube.com\/?p=68176"},"modified":"2026-06-15T20:25:07","modified_gmt":"2026-06-15T12:25:07","slug":"qingfeng-pharmaceutical-group-partners-with-tasco-pharma-to-commercialize-anti-tumor-and-cns-medicines-in-vietnam","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=68176","title":{"rendered":"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Qingfeng Pharmaceutical Group<\/strong> announced a strategic <strong>commercialization cooperation agreement<\/strong> with <strong>Vietnam&#8217;s TASCO PHARMA<\/strong> for the distribution of <strong>ten pharmaceutical products<\/strong> in the Vietnamese market. The partnership focuses on <strong>anti-tumor<\/strong> and <strong>central nervous system (CNS)<\/strong> therapeutic areas, aiming to enhance access to high-quality medicines for Vietnamese patients.<\/p>\n\n\n\n<h2 id=\"h-partnership-structure\" class=\"wp-block-heading\">Partnership Structure<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Role<\/th><th>Entity<\/th><th>Responsibilities<\/th><\/tr><\/thead><tbody><tr><td><strong>Drug Filing Applicant &amp; MAH<\/strong><\/td><td>Qingfeng Pharmaceutical Group<\/td><td>Regulatory submissions, product registration, and market authorization<\/td><\/tr><tr><td><strong>Exclusive Commercial Distributor<\/strong><\/td><td>TASCO PHARMA<\/td><td>Import, promotion, marketing, and sales across Vietnam<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-product-portfolio-highlights\" class=\"wp-block-heading\">Product Portfolio Highlights<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Therapeutic Focus:<\/strong> Anti-tumor and Central Nervous System (CNS) medications<\/li>\n\n\n\n<li><strong>Product Count:<\/strong> Ten established pharmaceutical products<\/li>\n\n\n\n<li><strong>Market Strategy:<\/strong> Leverage complementary strengths to provide accessible and affordable treatment options<\/li>\n\n\n\n<li><strong>Target Beneficiaries:<\/strong> Vietnamese healthcare providers and patients seeking quality oncology and neurological treatments<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-strategic-rationale\" class=\"wp-block-heading\">Strategic Rationale<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The collaboration capitalizes on <strong>Qingfeng Pharma&#8217;s<\/strong> robust product pipeline and regulatory expertise as a <strong>Market Authorization Holder (MAH)<\/strong>, combined with <strong>TASCO PHARMA&#8217;s<\/strong> extensive distribution network and local market knowledge in Vietnam. This partnership aligns with both companies&#8217; missions to expand access to essential medicines in emerging markets.<\/p>\n\n\n\n<h2 id=\"h-vietnam-pharmaceutical-market-context\" class=\"wp-block-heading\">Vietnam Pharmaceutical Market Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Size:<\/strong> Vietnam&#8217;s pharmaceutical market valued at approximately <strong>$7.5 billion<\/strong> in 2025, with projected <strong>8-10% annual growth<\/strong><\/li>\n\n\n\n<li><strong>Oncology Demand:<\/strong> Rising cancer incidence rates driving increased demand for anti-tumor therapies<\/li>\n\n\n\n<li><strong>CNS Treatment Gap:<\/strong> Limited access to advanced neurological medications creates significant unmet medical needs<\/li>\n\n\n\n<li><strong>Regulatory Environment:<\/strong> Vietnam&#8217;s Ministry of Health has streamlined drug approval processes for imported medicines from qualified international manufacturers<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-expected-impact-amp-timeline\" class=\"wp-block-heading\">Expected Impact &amp; Timeline<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Implementation:<\/strong> Regulatory filings expected to commence within Q3 2026<\/li>\n\n\n\n<li><strong>Market Entry:<\/strong> Initial product launches anticipated in H1 2027<\/li>\n\n\n\n<li><strong>Patient Access:<\/strong> Partnership aims to reduce treatment costs by 15-25% compared to existing premium-priced alternatives<\/li>\n\n\n\n<li><strong>Geographic Coverage:<\/strong> Nationwide distribution through TASCO PHARMA&#8217;s established hospital and retail pharmacy network<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding partnership implementation, regulatory timelines, and market expectations. Actual results may differ due to risks including regulatory approvals, competitive dynamics, and market adoption rates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Qingfeng Pharmaceutical Group announced a strategic commercialization cooperation agreement with Vietnam&#8217;s TASCO PHARMA for the&#8230;<\/p>\n","protected":false},"author":1,"featured_media":68178,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[3939,4796],"class_list":["post-68176","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-qingfeng-pharmaceutical","tag-tasco-pharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Qingfeng Pharmaceutical Group announced a strategic commercialization cooperation agreement with Vietnam&#039;s TASCO PHARMA for the distribution of ten pharmaceutical products in the Vietnamese market. The partnership focuses on anti-tumor and central nervous system (CNS) therapeutic areas, aiming to enhance access to high-quality medicines for Vietnamese patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=68176\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam\" \/>\n<meta property=\"og:description\" content=\"Qingfeng Pharmaceutical Group announced a strategic commercialization cooperation agreement with Vietnam&#039;s TASCO PHARMA for the distribution of ten pharmaceutical products in the Vietnamese market. The partnership focuses on anti-tumor and central nervous system (CNS) therapeutic areas, aiming to enhance access to high-quality medicines for Vietnamese patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=68176\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-15T12:25:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-15T12:25:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/1501-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam\",\"datePublished\":\"2026-06-15T12:25:05+00:00\",\"dateModified\":\"2026-06-15T12:25:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176\"},\"wordCount\":338,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/1501-1.webp\",\"keywords\":[\"Qingfeng Pharmaceutical\",\"TASCO PHARMA\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=68176#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=68176\",\"name\":\"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/1501-1.webp\",\"datePublished\":\"2026-06-15T12:25:05+00:00\",\"dateModified\":\"2026-06-15T12:25:07+00:00\",\"description\":\"Qingfeng Pharmaceutical Group announced a strategic commercialization cooperation agreement with Vietnam's TASCO PHARMA for the distribution of ten pharmaceutical products in the Vietnamese market. The partnership focuses on anti-tumor and central nervous system (CNS) therapeutic areas, aiming to enhance access to high-quality medicines for Vietnamese patients.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=68176\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/1501-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/1501-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68176#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam - Insight, China&#039;s Pharmaceutical Industry","description":"Qingfeng Pharmaceutical Group announced a strategic commercialization cooperation agreement with Vietnam's TASCO PHARMA for the distribution of ten pharmaceutical products in the Vietnamese market. The partnership focuses on anti-tumor and central nervous system (CNS) therapeutic areas, aiming to enhance access to high-quality medicines for Vietnamese patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=68176","og_locale":"en_US","og_type":"article","og_title":"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam","og_description":"Qingfeng Pharmaceutical Group announced a strategic commercialization cooperation agreement with Vietnam's TASCO PHARMA for the distribution of ten pharmaceutical products in the Vietnamese market. The partnership focuses on anti-tumor and central nervous system (CNS) therapeutic areas, aiming to enhance access to high-quality medicines for Vietnamese patients.","og_url":"https:\/\/flcube.com\/?p=68176","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-15T12:25:05+00:00","article_modified_time":"2026-06-15T12:25:07+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/1501-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=68176#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=68176"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam","datePublished":"2026-06-15T12:25:05+00:00","dateModified":"2026-06-15T12:25:07+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=68176"},"wordCount":338,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=68176#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/1501-1.webp","keywords":["Qingfeng Pharmaceutical","TASCO PHARMA"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=68176#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=68176","url":"https:\/\/flcube.com\/?p=68176","name":"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=68176#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=68176#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/1501-1.webp","datePublished":"2026-06-15T12:25:05+00:00","dateModified":"2026-06-15T12:25:07+00:00","description":"Qingfeng Pharmaceutical Group announced a strategic commercialization cooperation agreement with Vietnam's TASCO PHARMA for the distribution of ten pharmaceutical products in the Vietnamese market. The partnership focuses on anti-tumor and central nervous system (CNS) therapeutic areas, aiming to enhance access to high-quality medicines for Vietnamese patients.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=68176#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=68176"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=68176#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/1501-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/1501-1.webp","width":1080,"height":608,"caption":"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=68176#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Qingfeng Pharmaceutical Group Partners with TASCO PHARMA to Commercialize Anti-Tumor and CNS Medicines in Vietnam"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/1501-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/68176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=68176"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/68176\/revisions"}],"predecessor-version":[{"id":68179,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/68176\/revisions\/68179"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/68178"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=68176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=68176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=68176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}